Detalhe da pesquisa
1.
Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Nature
; 607(7917): 149-155, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705813
2.
Antigen discovery for the development of cancer immunotherapy.
Semin Immunol
; 66: 101733, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841147
3.
The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.
J Biol Chem
; 295(31): 10535-10559, 2020 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299913
4.
Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33807608
5.
p66ShcA functions as a contextual promoter of breast cancer metastasis.
Breast Cancer Res
; 22(1): 7, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31941526
6.
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model.
Front Immunol
; 14: 1297932, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213329
7.
Investigative needle core biopsies for multi-omics in Glioblastoma.
medRxiv
; 2023 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38234840
8.
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.
JCI Insight
; 6(4)2021 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470989
9.
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.
Nat Commun
; 12(1): 3299, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083537
10.
CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers.
Cancer Res
; 80(3): 444-457, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722999
11.
Integration of Distinct ShcA Signaling Complexes Promotes Breast Tumor Growth and Tyrosine Kinase Inhibitor Resistance.
Mol Cancer Res
; 16(5): 894-908, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29453318
12.
Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
Cancer Res
; 78(17): 4826-4838, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29930100
13.
The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.
Nat Commun
; 8: 14638, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28276425
14.
Analyzing the Tumor Microenvironment by Flow Cytometry.
Methods Mol Biol
; 1458: 95-110, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581017
15.
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.
Cancer Res
; 76(6): 1416-28, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26719528
16.
p66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition.
Mol Cell Biol
; 34(19): 3689-701, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25071152
17.
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
Cancer Res
; 73(14): 4521-32, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23695548